In the United States, an estimated 52.9% of the population is fully vaccinated against COVID-19; whereas, about 41.2% of the population is fully vaccinated in Georgia. As of mid-August 2021, 23 rural Georgia counties had over 100% of hospital beds filled. Most people who are hospitalized due to COVID-19 are unvaccinated. In fact, a research study conducted by the CDC found that people who are unvaccinated are about 29 times more likely to be hospitalized with COVID-19, compared to those who are fully vaccinated. Even with the more contagious Delta variant, people who are unvaccinated are about 5 times more likely to be infected with COVID-19 than those who are fully vaccinated.
People who are unvaccinated are more at risk for contracting severe COVID-19, which is defined as COVID-19 with one of the following additional features: clinical signs at rest that are indicative of severe systemic illness; respiratory illness; respiratory failure; evidence of shock; significant acute renal, hepatic, or neurologic dysfunction; admission to an intensive care unit; or death. Thus, it is critical for people to be fully vaccinated to reduce their risk of contracting severe COVID-19.
Currently, the three vaccines authorized and recommended in the United States to prevent COVID-19 are Pfizer-BioNTech, Moderna, and Johnson & Johnson/Janssen. A two-dose regimen of the Pfizer-BioNTech vaccine has conferred at least 95% protection against COVID-19 in persons 12 years of age or older, the two-dose Moderna vaccine has shown 94.1% efficacy at preventing COVID-19 illness and severe COVID-19 manifestations, and the single-dose Johnson & Johnson/Janssen vaccine has been shown to protect against symptomatic COVID-19, asymptomatic SARS-CoV-2 infection, and severe COVID-19.
Article Submitted by Dahlia Al-Haleem, MSES, PhD Research Assistant
Griffin JB, Haddix M, Danza P, et al. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status — Los Angeles County, California, May 1–July 25, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1170–1176. DOI: http://dx.doi.org/10.15585/mmwr.mm7034e5
Hannah Ritchie, Edouard Mathieu, Lucas Rodés-Guirao, Cameron Appel, Charlie Giattino, Esteban Ortiz-Ospina, Joe Hasell, Bobbie Macdonald, Diana Beltekian and Max Roser (2020) – “Coronavirus Pandemic (COVID-19)”. Published online at OurWorldInData.org. Retrieved from: ‘https://ourworldindata.org/coronavirus’
Wallace M, Woodworth KR, Gargano JW, et al. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021. MMWR Morb Mortal Wkly Rep 2021;70:749–752. DOI: http://dx.doi.org/10.15585/mmwr.mm7020e1
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., McGettigan, J., Khetan, S., Segall, N., Solis, J., Brosz, A., Fierro, C., Schwartz, H., Neuzil, K., Corey, L., … Zaks, T. (2021). Efficacy and safety of the mrna-1273 sars-cov-2 vaccine. New England Journal of Medicine, 384(5), 403–416. https://doi.org/10.1056/nejmoa2035389
Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., Offergeld, K., Scheper, G., Taylor, K. L., Robb, M. L., Treanor, J., Barouch, D. H., Stoddard, J., Ryser, M. F., Marovich, M. A., … Douoguih, M. (2021). Safety and efficacy of single-dose ad26.cov2.s vaccine against covid-19. New England Journal of Medicine, 384(23), 2187–2201. https://doi.org/10.1056/nejmoa2101544
Ye, P., Fry, L., Liu, H., Ledesma, S., & Champion, J. D. (2021). COVID outbreak after the 1ST dose of COVID vaccine among the nursing home residents: What happened? Geriatric Nursing, 42(5), 1105–1108. https://doi.org/10.1016/j.gerinurse.2021.06.022